Experimental Drug That Targets BRAF Cancer Gene Shows Promise Against Metastatic Melanoma
Links shared publicly online about this topic.
- 954total visits
Experimental Drug That Targets BRAF Cancer Gene Shows Promise Against Metastatic Melanoma
A phase 1 clinical trial using a new formulation of an experimental drug that targets the BRAF cancer gene, has shown early promise in treating melanoma in patients with a mutated form of the ge
View full resource at medicalnewstoday.com
Most Recently Shared on August 30, 2010 at 5:29 pm By:
Remarkable new treatment for metastatic melanoma? 81% of people with specific mutation respond. Phase 3 trials underway http://bit.ly/a5YSjl
Also Shared By:
Advertisement
American Nurse Today
@AmerNurse2day
Experimental drug shows promise in fight against Metastatic Melanoma. http://fb.me/FdKYkB2Z
1 year ago...